MedTrace Logo

Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis

NCT03506386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 943

Last updated 2021-02-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to present a descriptive analysis of demographic and clinical characteristics of the participants, as well as of the treatment patterns for multiple myeloma (MM) in Brazil.

Conditions

Interventions

OTHER

No Intervention

As it was an observational study, no intervention was administered.

Sponsors & Collaborators

Principal Investigators

  • Medical Monitor Clinical Science · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-09
Primary Completion
2019-11-08
Completion
2020-01-27

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03506386 on ClinicalTrials.gov